Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kelly Timothy Edwin, holds the title of Chief Financial Officer at Praxis Precision Medicines, Inc..
On 2026-11-13, the insider transacted 3 shares.The shares were transacted at a weighted average price of $278.91 per share, resulting in a total market-relevant value of $836.73.
Kelly Timothy Edwin (Chief Financial Officer) was granted $837 of $PRAX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.